NPA-101-3

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNPA-101-3
Drug Alias NameNPA-101-3NPA101.3NPA-101.3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsTyrosine-protein kinase receptor RET inhibitors
TargetsVascular endothelial growth factor receptor 2Tyrosine-protein kinase receptor RET
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversità Degli Studi Di Napoli Federico Ii
China Registration ClassN/A

Develop Information

Active CompaniesUniversità Degli Studi Di Napoli Federico Ii
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A